John L. Higgins

2013

In 2013, John L. Higgins earned a total compensation of $3M as President and Chief Executive Officer at Ligand Pharmaceuticals, a 27% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$375,248
Option Awards$1,567,129
Salary$500,331
Stock Awards$559,360
Other$2,843
Total$3,004,911

Higgins received $1.6M in option awards, accounting for 52% of the total pay in 2013.

Higgins also received $375.2K in non-equity incentive plan, $500.3K in salary, $559.4K in stock awards and $2.8K in other compensation.

Rankings

In 2013, John L. Higgins' compensation ranked 2,540th out of 12,286 executives tracked by ExecPay. In other words, Higgins earned more than 79.3% of executives.

ClassificationRankingPercentile
All
2,540
out of 12,286
79th
Division
Manufacturing
836
out of 4,612
82nd
Major group
Chemicals And Allied Products
223
out of 1,466
85th
Industry group
Drugs
148
out of 1,160
87th
Industry
Pharmaceutical Preparations
126
out of 890
86th
Source: SEC filing on April 12, 2016.

Higgins' colleagues

We found four more compensation records of executives who worked with John L. Higgins at Ligand Pharmaceuticals in 2013.

2013

Matthew Foehr

Ligand Pharmaceuticals

Chief Operating Officer

2013

Nishan de Silva

Ligand Pharmaceuticals

Chief Financial Officer

2013

John Sharp

Ligand Pharmaceuticals

Chief Financial Officer

2013

Charles Berkman

Ligand Pharmaceuticals

General Counsel

News

In-depth

You may also like